# Eli Lilly and Company (LLY) — Q3-2025 Earnings Results

**Report date:** 2025-10-30 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q3-2025

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Up 3.81%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $7.02 | N/A | +16.59% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based on numerical results only.

### Guidance Changes

No guidance data is available.

### What It Means

Eli Lilly reported a strong earnings per share figure that exceeded expectations, contributing to a positive stock reaction of 3.81%. However, without revenue data or management commentary, it's difficult to assess the full context of the company's performance. Investors may view the EPS beat as a positive sign for future profitability.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q3-2025_